|
시장보고서
상품코드
1360075
남미의 임상시험 이미징 시장 예측(-2028년) : 지역별 분석 - 모달리티, 오퍼링, 최종사용자별South America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User |
||||||
남미의 임상시험 이미징 시장은 2023년 8,963만 달러에서 2028년에는 1억 2,352만 달러로 성장할 것으로 예측되며, 2023-2028년의 CAGR은 6.6%로 추정됩니다.
의료 영상 서비스를 제공하는 CRO 수의 급증이 남미의 임상시험 영상 시장을 지원
임상연구기관(CRO)은 우수한 시설과 전문성을 바탕으로 제공하는 서비스를 통해 임상시험의 성공을 돕고 있으며, CRO는 효율적이고 비용 효율적인 운영을 통해 임상시험 의뢰자에게 이익을 가져다주며 임상시험 산업의 중추적인 역할을 담당하고 있습니다. 예를 들어 CRO가 임상시험을 수행하고 완료하는 데 소요되는 시간은 사내 활동보다 평균 30% 더 짧습니다. CRO의 수가 증가하고 경쟁이 치열해지면서, 일부 기업은 이미징에 특화된 서비스를 제공하며 이미징 CRO(iCRO)로 부상하고 있습니다. Medical Imaging과 Medica Group PLC는 iCRO의 대표적인 사례로, CRO는 이미징 수행기관 인증, 표준화된 이미지 획득, 판독 설계 및 기준 결정 등의 분야에서 중요한 지식을 제공함으로써 남미 임상시험 이미징 시장 전체의 성장에 기여하고 있습니다.
남미 임상시험 이미징 시장 개요
남미 임상시험 이미징 시장은 아르헨티나, 브라질, 기타 남미로 구분됩니다. 브라질은 2022년 가장 큰 점유율을 차지하며 예측 기간 중 7.2%의 CAGR을 나타낼 것으로 예상됩니다. 임상시험 증가 시장 진출기업의 주요 기술 혁신, 임상시험 이미징을 지원하기 위한 정부의 구상 등이 시장 성장을 가속하는 요인으로 꼽힙니다. Clinical Trials Arena에 따르면 2021년 브라질은 세계 임상시험 활동의 1.7%를 차지할 것으로 예상되며, 2022년 7월 보스턴 CRO는 리우데자네이루에 위치한 이 지역 최대 규모의 연구센터인 IBPClin은 브라질 12개 주에서 7,000명 이상의 참가자를 등록하고 160개 이상의 업계 주최 임상시험을 수행한 바 있으며, 브라질 최대 규모의 연구센터인 Instituto Brasil de Pesquisa Clinica(IBPClin)를 인수해 라틴아메리카가 분산형 임상시험 제공 모델을 도입하는 첫 번째 단계가 되었다고 밝혔습니다. 조사를 실시했다고 밝혔습니다.
남미 임상시험 이미징 시장 매출 및 2028년까지의 예측(금액)
남미 임상시험 이미징 시장 세분화
남미 임상시험 이미징 시장은 양식, 제공 제품, 최종사용자, 국가별로 분류됩니다. 양식에 따라 남미 임상시험 이미징 시장은 단층촬영, 자기공명영상(MRI), 초음파, 양전자방출단층촬영(PET), 엑스레이, 심초음파, 기타로 분류되며, 2023년에는 단층촬영 부문이 가장 큰 시장 점유율을 기록할 것으로 예상됩니다.
남미 임상시험 이미징 시장은 제공 서비스를 기준으로 운영 이미징 서비스, 이미징 소프트웨어, 판독 및 분석 서비스, 시험 설계 및 컨설팅 서비스, 기타로 분류됩니다. 운영 이미징 서비스 부문이 2023년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
최종사용자별로 남미 임상시험 이미징 시장은 CRO, 제약 및 생명공학 기업, 학술 및 연구 기관, 기타로 구분되며, 2023년에는 CRO 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
국가별로 보면 시장은 아르헨티나, 브라질, 기타 남미로 구분됩니다. 브라질이 2023년의 시장 점유율을 독점했습니다.
eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, VIDA Diagnostics Inc, WCG Clinical Inc가 남미 임상시험 이미징 시장에서 사업을 운영하는 주요 기업입니다.
목차
제1장 서론
제2장 남미의 임상시험 이미징 시장 - 요점
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 남미의 임상시험 이미징 시장 - 시장 구도
- 남미의 PEST 분석
- 전문가의 견해
제5장 남미의 임상시험 이미징 시장 : 주요 시장 역학
- 시장 촉진요인
- 제약·바이오테크놀러지 업계에서 임상시험 활동의 가속
- 메디컬 이미징 서비스를 제공하는 CRO 수의 급증
- 시장 억제요인
- 고액 투자와 표준화된 인프라 요건
- 시장 기회
- 인실리코 이미징 임상시험
- 향후 동향
- AI 주도형 임상시험
- 영향 분석
제6장 남미 임상시험 이미징 시장
- 남미의 임상시험 이미징 시장 매출과 예측 분석
제7장 남미의 임상시험 이미징 시장 매출과 2028년까지의 예측 - 모달리티별
- 남미의 임상시험 이미징 시장 모달리티별 매출 점유율(2022년, 2028년)
- 토모그래피
- 초음파
- PET(Positron Emission Tomography)
- X선
- 심에코
- 자기공명영상법
- 기타
제8장 남미의 임상시험 이미징 시장 매출과 2028년까지의 예측 - 제공
- 남미의 임상시험 이미징 시장 오퍼링별 매출 점유율(2022년 및 2028년)
- 임상시험 디자인 컨설팅 서비스
- Read Analysis Services
- 이미징 운영 서비스
- 이미징 소프트웨어
- 기타
제9장 남미의 임상시험 이미징 시장 매출과 2028년까지의 예측 - 최종사용자별
- 제약회사 및 바이오 제약회사
- 계약 연구기관
- 학술·연구기관
- 기타
제10장 남미의 임상시험 이미징 시장 : 매출과 2028년까지의 예측 : 국가별 분석
- 남미
- 브라질
- 아르헨티나
- 기타 남미
제11장 남미의 임상시험 이미징 시장미나미 쌀 임상시험 이미징 시장 : 업계 상황
- 무기적 성장 전략
- 유기적 성장 전략
제12장 기업 개요
- eResearch Technology Inc
- ICON PLC
- VIDA Diagnostics Inc
- WCG Clinical Inc
- Medical Metrics Inc
- IXICO plc
제13장 부록
KSA 23.10.19The South America clinical trial imaging market is expected to grow from US$ 89.63 million in 2023 to US$ 123.52 million by 2028; it is estimated to register a CAGR of 6.6% from 2023 to 2028.
Spur in Number of CROs Offering Medical Imaging Services Fuels South America Clinical Trial Imaging Market
Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. For example, on an average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials. With the rising number of CROs leading to high competition, some of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). Keosys Medical Imaging and Medica Group PLC are the iCROs examples. The CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall South America clinical trial imaging market.
South America Clinical Trial Imaging Market Overview
The South America clinical trial imaging market is segmented into Argentina, Brazil, and the Rest of South America. Brazil held the largest share in 2022, and it is expected to register a CAGR of 7.2% during the forecast period. A rise in clinical trials, key innovation by market players, and government initiatives to support clinical trial imaging are a few factors fueling the market growth. Brazil is a major destination for clinical trials. According to Clinical Trials Arena, in 2021, Brazil accounted for 1.7% share of the global clinical trials activity. In July 2022, Boston CRO acquired Rio de Janeiro-based Instituto Brasil de Pesquisa Clinica (IBPClin), the largest research center in the region, describing it as the first step towards Latin America's adoption of its decentralized clinical trial delivery model. It claims to have conducted more than 160 industry-sponsored research studies, enrolling more than 7,000 participants across 12 Brazilian states.
South America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
South America Clinical Trial Imaging Market Segmentation
The South America clinical trial imaging market is segmented on the basis of modality, offering, end user, and country. Based on modality, the South America clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.
Based on offering, the South America clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.
Based on end user, the South America clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.
Based on country, the market is segmented into Argentina, Brazil, and the Rest of South America. Brazil dominated the market share in 2023.
eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the South America clinical trial imaging market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America clinical trial imaging market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South America clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies
- develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South America market trends and outlook coupled with the factors driving the clinical trial imaging market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 South America Market Segmentation
- 1.3.1 South America Clinical Trial Imaging Market - by Modality
- 1.3.2 South America Clinical Trial Imaging Market - by Offering
- 1.3.3 South America Clinical Trial Imaging Market - by End User
- 1.3.4 South America Clinical Trial Imaging Market - by Country
2. South America Clinical Trial Imaging Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. South America Clinical Trial Imaging Market - Market Landscape
- 4.1 Overview
- 4.1.1 South America PEST Analysis
- 4.2 Expert Opinion
5. South America Clinical Trial Imaging Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
- 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
- 5.2 Market Restraints
- 5.2.1 High Investment and Standardized Infrastructure Requirements
- 5.3 Market Opportunities
- 5.3.1 In-Silico Imaging Clinical Trials
- 5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
- 5.5 Impact Analysis
6. South America Clinical Trial Imaging Market
- 6.1 South America Clinical Trial Imaging Market Revenue Forecast and Analysis
7. South America Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality
- 7.1 Overview
- 7.2 South America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
- 7.3 Tomography
- 7.3.1 Overview
- 7.3.2 Tomography: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Ultrasound
- 7.4.1 Overview
- 7.4.2 Ultrasound: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5 Positron Emission Tomography
- 7.5.1 Overview
- 7.5.2 PET: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6 X-Ray
- 7.6.1 Overview
- 7.6.2 X-Ray: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.7 Echocardiography
- 7.7.1 Overview
- 7.7.2 Echocardiography: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8 Magnetic Resonance Imaging
- 7.8.1 Overview
- 7.8.2 Magnetic Resonance Imaging: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8. South America Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering
- 8.1 Overview
- 8.2 South America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
- 8.3 Trial Design Consulting Services
- 8.3.1 Overview
- 8.3.2 Trial Design Consulting Services: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Read Analysis Services
- 8.4.1 Overview
- 8.4.2 Read Analysis Services: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Operational Imaging Services
- 8.5.1 Overview
- 8.5.2 Operational Imaging Services: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.6 Imaging Software
- 8.6.1 Overview
- 8.6.2 Imaging Software: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9. South America Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User
- 9.1 Overview
- 9.2 Pharmaceutical and Biopharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biopharmaceutical Companies: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 9.3 Contract Research Organizations
- 9.3.1 Overview
- 9.3.2 Contract Research Organizations: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Academic and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic and Research Institutes: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
10. South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Country Analysis
- 10.1 Overview
- 10.1.1 South America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
- 10.1.1.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2 Overview
- 10.1.1.2.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.2 Brazil: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
- 10.1.1.2.3 Brazil: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
- 10.1.1.2.4 Brazil: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.3 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.2 Argentina: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
- 10.1.1.3.3 Argentina: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
- 10.1.1.3.4 Argentina: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
- 10.1.1.4 Rest of South America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Rest of South America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.2 Rest of South America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
- 10.1.1.4.3 Rest of South America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
- 10.1.1.4.4 Rest of South America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
- 10.1.1 South America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
11. South America Clinical Trial Imaging Market - Industry Landscape
- 11.1 Overview
- 11.2 Inorganic Growth Strategies
- 11.2.1 Overview
- 11.3 Organic Growth Strategies
- 11.3.1 Overview
12. Company Profiles
- 12.1 eResearch Technology Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 ICON PLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 VIDA Diagnostics Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 WCG Clinical Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Medical Metrics Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 IXICO plc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
